Genetics | A.D.A.M. Innovations

top of page

Services
Our science
About
CSR
Careers
News
Events
More

Use tab to navigate through the menu items.

A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine

A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine

A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine

Apr 30

A.D.A.M. Innovations Unveils GeneLock™ The World’s First Genetic Data Protection Platform

A.D.A.M. Innovations Unveils GeneLock™ The World’s First Genetic Data Protection Platform

A.D.A.M. Innovations Unveils GeneLock™ The World’s First Genetic Data Protection Platform

Apr 24

DNA DAY™ 2026: GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration

DNA DAY™ 2026: GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration

DNA DAY™ 2026: GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration

Apr 24

GeneLife Brings Faster Results and Real-time Tracking for DNA DAY™ 2026

GeneLife Brings Faster Results and Real-time Tracking for DNA DAY™ 2026

GeneLife Brings Faster Results and Real-time Tracking for DNA DAY™ 2026

Apr 24

Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan

Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan

Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan

Mar 17

The World’s First AI Genomic-Based Skincare LineDesigned to Address Japanese and Asian Environmental Skin Aging

The World’s First AI Genomic-Based Skincare LineDesigned to Address Japanese and Asian Environmental Skin Aging

A.D.A.M. Innovations Announces the Launch of ALUNAÉ

Dec 9, 2025

GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models

GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models

GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models

Dec 5, 2025

A.D.A.M. Innovations Launches GeneLink, the World’s First Genetics-Powered Ad Platform

A.D.A.M. Innovations Launches GeneLink, the World’s First Genetics-Powered Ad Platform

A.D.A.M. Innovations Launches GeneLink, the World’s First Genetics-Powered Ad Platform

Oct 2, 2025

AI Magazine Reports on A.D.A.M. Innovations and GeneLink its AI-Genomics Ad-tech Platform

AI Magazine Reports on A.D.A.M. Innovations and GeneLink its AI-Genomics Ad-tech Platform

AI Magazine Reports on A.D.A.M. Innovations and GeneLink its AI-Genomics Ad-tech Platform

Oct 2, 2025

Genesis Healthcare Becomes A.D.A.M. Innovations

Genesis Healthcare Becomes A.D.A.M. Innovations

Genesis Healthcare Becomes A.D.A.M. Innovations, Steering the Next Chapter of AI-Driven Genomics

Oct 1, 2025

GenesisGaia featured on GenomeWeb

GenesisGaia featured on GenomeWeb

GenesisGaia featured on GenomeWeb

Jul 19, 2023

Covid PCR testing

Related sites

Phone number

+81-(0)3-5422-8506 (Japan)

Location

Yebisu Garden Place Tower 26F, 4-20-3 Ebisu, Shibuya-ku,
Tokyo, 150-6026,
JAPAN

Compliance rules

© 2026 A.D.A.M. Innovations Co. (Japanese corporate name Genesis Healthcare Co.). All rights reserved.

GeneLife, GeneLife WGS, GenesisGaia and GeneLink are registered or pending registration trademarks of A.D.A.M. Innovations Co. (Japanese corporate name Genesis Healthcare Co.)

bottom of page